Initiation of therapy with SGLT-2 inhibitors for T2D mellitus is not associated with an increased risk for UTI events compared with initiation of other second-line antidiabetic medications.
The FDA has approved Recarbrio for the treatment of adult patients aged 18 years and older with complicated UTI.
Different infection types, especially UTI, are associated with subsequent acute ischemic stroke.
A significant percentage of patients with uncomplicated urinary tract infection (UTI) are treated with an empiric antibiotic agent to which the etiologic bacteria is resistant.
Fosfomycin for injection may show promise and noninferiority compared with standard treatment for complicated urinary tract infections.
For children with a normal urinary tract, probiotics were more effective than placebo at reducing the risk for UTI after the first episode of a febrile UTI.
Long-term antibiotics to prevent recurrent urinary tract infections (UTIs) in children offer a modest benefit but may increase the occurrence of UTIs caused by resistant bacteria.
Patients with suspected urinary tract infection syndromes may be unnecessarily prescribed antibiotics.
A new clinical guideline on the diagnosis and treatment of recurrent urinary tract infections in women was released by AUA.
No evidence seen for benefits of screening nonpregnant women or men for asymptomatic bacteriuria
